The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 346 participants.

Also called NCT01664247

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 346 participants (enrolled count) (from the registry)
Sponsor
  • Novo Nordisk Registry lists this organization as the lead sponsor
Registry
  • NCT NCT01664247
  • EudraCT 2011-004665-32
Main results
  • Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study) Diabetes, obesity & metabolism, 2016-07 DOI, PubMed 26990378, PMC5074260 PubMed links an erratum for this paper. Erratum: PMID 27546838 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Canada, France, Germany, Israel, Italy, Serbia, South Africa, Ukraine, United Arab Emirates, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01664247. Randomized; double masking; primary purpose treatment. Start 2012-10-01 (actual); primary completion 2013-12-31 (actual). Results posted on 2016-04-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Effect of Insulin Degludec in Combination With Liraglutide and Metformin in Subjects With Type 2 Diabetes Qualifying for Treatment Intensification
Condition
Diabetes
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
insulin degludec
Intervention (Drug)
placebo
Intervention (Drug)
liraglutide
Lead sponsor
Novo Nordisk A/S (class: industry)

Record details

Record id
cardio:ct-nct01664247
Content hash
ece750d0119add4467e64c364fd16500ad1be259332326771950adbabe230e5a